RT Journal Article
SR Electronic
T1 Phylogenomics and phylodynamics of SARS-CoV-2 retrieved genomes from India
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.23.20138222
DO 10.1101/2020.06.23.20138222
A1 Sameera Farah
A1 Ashwin Atkulwar
A1 Manas Ranjan Praharaj
A1 Raja Khan
A1 Ravikumar Gandham
A1 Mumtaz Baig
YR 2020
UL http://medrxiv.org/content/early/2020/06/26/2020.06.23.20138222.abstract
AB The ongoing SARS-CoV-2 pandemic is one of the biggest outbreaks after the Spanish flu of 1918. Understanding the epidemiology of viral outbreaks is the first step towards vaccine development programs. This is the first phylodynamics study attempted on of SARS-CoV-2 genomes from India to infer its current evolution in the context of an ongoing pandemic. Out of 286 retrieved SARS-CoV-2 whole genomes from India, 138 haplotypes were generated and analyzed. Median-joining network was built to investigate the relatedness of SARS-CoV-2 haplotypes in India. The BDSIR package of BEAST2 was used to calculate the reproduction number (R0) and the infectious rate of the virus. Past and current population trend was investigated using the stamp date method in coalescent Bayesian skyline plot, implemented in BEAST2 and by exponential growth prior in BEAST 1.10.4. Median-joining network reveals two distinct ancestral clusters A and B showing genetic affinities with Wuhan outbreak sample. The network also illustrates the autochthonous development of isolates in a few instances. High basic reproduction number of SARS-nCoV-2 in India points towards the phase of active community transmission. The Bayesian skyline plot revel exponential rise in the effective population size (Ne) of Indian isolates from the first week of January to the first week of April 2020. More genome sequencing and analyses of the virus will be required in coming days to monitor COVID19 after the upliftment of lock down in India.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe gratefully acknowledge all authors and submitting laboratories of the sequences from GISAID. Sameera Farah and Mumtaz Baig are thankful to Prof. Elizabeth Boulding and Compute Canada for providing access to high computation facilities at www.cedar.computecanada.caAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Study is purely based on the bioinformatic analysis of already deposited SARS-CoV-2 sequences from India. We have acknowledged the respective labs and researchers who contributed these sequences to the GIASID database.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe dataset of the sequences used in this study is provided with the manuscript.